| Sources | Names Used |
|---|---|
| CTRPv2 | Compound 1541A |
| PharmacoGx | Compound 1541A |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TEX33 | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-27 |
| mRNA | MALRD1 | CTRPv2 | pan-cancer | AAC | 0.35 | 7e-21 |
| mRNA | AC100821.1 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-19 |
| mRNA | ARHGDIG | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-15 |
| mRNA | TBX3 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-11 |
| mRNA | AC008759.1 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | AL445183.1 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | DISP2 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-10 |
| mRNA | ZNF554 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |
